original ) (raw )Antibody-dependent cellular cytotoxicity against HIV-1 in sera of immunized chimpanzees
Mark Connors
AIDS, 1991
View PDFchevron_right
Protection of MN-rgp120-Immunized Chimpanzees from Heterologous Infection with a Primary Isolate of Human Immunodeficiency Virus Type 1
Phillip Berman
Journal of Infectious Diseases, 1996
View PDFchevron_right
Simian Immunodeficiency Virus DNA Vaccine Trial in Macaques
Farah Mustafa
Annals of the New York Academy of Sciences, 1995
View PDFchevron_right
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Phillip Berman
New England Journal of Medicine, 2012
View PDFchevron_right
Mucosal immunity and HIV/AIDS vaccines
Marc GIRARD
Vaccine, 2008
View PDFchevron_right
Simian Immunodeficiency Virus-Induced CD4+T Cell Deficits in Cytokine Secretion Profile Are Dependent on Monkey Origin
Debbie Watry
Viral Immunology, 2006
View PDFchevron_right
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
Fred Peyerl
Nature, 2002
View PDFchevron_right
Risk to Human Health from a Plethora of Simian Immunodeficiency Viruses in Primate Bushmeat
Florian Liegeois
Emerging Infectious Diseases, 2002
View PDFchevron_right
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus
Marc GIRARD
Proceedings of the National Academy of Sciences, 1991
View PDFchevron_right
Lessons in Nonhuman Primate Models for AIDS Vaccine Research: From Minefields to Milestones
Nancy Haigwood
Cold Spring Harbor Perspectives in Medicine, 2012
View PDFchevron_right
Acute Loss of Intestinal CD4+ T Cells Is Not Predictive of Simian Immunodeficiency Virus Virulence
Alan Perelson
The Journal of Immunology, 2007
View PDFchevron_right
HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees
Myriam Francotte
Vaccine, 1994
View PDFchevron_right
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques
Lance Wells
Nature, 2019
View PDFchevron_right
Differences in early virus loads with different phenotypic variants of HIV-1 and SIVcpz in chimpanzees
Henk Niphuis
AIDS, 2001
View PDFchevron_right
T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees
Trần Chánh
Journal of Virology, 1987
View PDFchevron_right
Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination
Henk Niphuis
Journal of General Virology, 1995
View PDFchevron_right
Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine
Matthew Gonda
Proceedings of the National Academy of Sciences, 1987
View PDFchevron_right
HIV-1 neutralizing antibody titers induced by vaccination correlate with protection from infection and decreased virus load in chimpanzees
jlh66@cam.ac.uk Heeney
View PDFchevron_right
Key Issues for a Potential Human Immunodeficiency Virus Vaccine
Dale Hu
Clinical Infectious Diseases, 2003
View PDFchevron_right
Characterization of simian immunodeficiency virus-specific T-cell-mediated cytotoxic response of infected rhesus macaques
Thomas Pertel
AIDS, 1989
View PDFchevron_right
Immunogenicity and Safety of Yellow Fever Vaccination for 102 HIV‐Infected Patients
Odile Launay
Clinical Infectious Diseases, 2009
View PDFchevron_right
Selective amplification of simian immunodeficiency virus genotypes after intrarectal inoculation of rhesus monkeys
Parul Trivedi
Journal of Virology, 1994
View PDFchevron_right
Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus
Karin Metzner
Journal of General Virology, 2005
View PDFchevron_right
Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge
Regina Hofmann-lehmann
Journal of Medical Primatology, 2002
View PDFchevron_right
Specific nature of cellular immune responses elicited by chimpanzees against HIV-1
jlh66@cam.ac.uk Heeney
Human immunology, 2003
View PDFchevron_right
The Consequence of Passive Administration of An Anti-Human Immunodeficiency Virus Type 1 Neutralizing Monoclonal Antibody Before Challenge of Chimpanzees With …
George Mark
Journal of …, 1996
View PDFchevron_right
The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate
Emilio Emini
Journal of virology, 1996
View PDFchevron_right
Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1
Kent Weinhold
Journal of Virology, 1995
View PDFchevron_right
Defects in cell-mediated immunity in HIV-1 infection: implications for immunotherapy and vaccine development
Mark Lowdell
Serodiagnosis and Immunotherapy in Infectious Disease, 1988
View PDFchevron_right
Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization
Shridhara Murthy
Nature Medicine, 1997
View PDFchevron_right
Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques
M. Yasunami
Journal of General Virology, 2007
View PDFchevron_right
Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees
William Mitchell
Proceedings of the National Academy of Sciences, 1989
View PDFchevron_right
Protection from Secondary Human Immunodeficiency Virus Type 1 Infection in Chimpanzees Suggests the Importance of Antigenic Boosting and a Possible Role for Cytotoxic T Cells
Petra Mooij , Willy Bogers
View PDFchevron_right
DNA vaccination as anti-human immunodeficiency virus immunotherapy in infected chimpanzees
Michael Agadjanyan
1997
View PDFchevron_right
Primate immunodeficiency virus classification and nomenclature: Review
Dimitrios Paraskevis
Infection, Genetics and Evolution, 2016
View PDFchevron_right